Elevating your organoid research
Since 2016, SUN bioscience has been revolutionizing Precision Health. Our mission is to empower personalized medicine by harnessing the potential of patient stem cells to identify the most effective drugs. At the heart of our groundbreaking efforts is our proprietary high-throughput 3D microwell platform, enabling the generation of standardized and reproducible organoids, without any effort.
SUN’s flagship technology Gri3D® overcomes the challenges in organoid culture: automation, robustness, scalability, and easy imaging – introducing a new era in drug development
Moving organoids from lab to real-world applications across industries and geographies
Academic collaborators and global corporations trust Gri3D® to standardize their organoid cultures, from intestinal organoids to 200 day old optic cups.